Literature DB >> 15501693

High glucose concentration augments angiotensin II mediated contraction via AT1 receptors in rat thoracic aorta.

K H S Arun1, C L Kaul, P Ramarao.   

Abstract

Elevated glucose concentration is implicated to play major role in development of diabetic associated vascular complications. It was previously reported that angiotensin II (Ang II) induced contractile response is enhanced in thoracic aorta of diabetic rats. In the present study, the effect of high glucose (HG, 25 mM) exposure for 2h on Ang II cumulative concentration response curves recorded isometrically was studied in thoracic aortic rings isolated from male Sprague-Dawley rats pretreated with streptozotocin (STZ, 65 mg kg(-1) i.p.) or vehicle at 8 weeks prior to the study. Ang II induced contraction via AT1 receptor was significantly enhanced (by 60 +/- 2 %) in HG exposed thoracic aortic rings isolated from vehicle treated but not STZ treated rats. However, there was no change in the pD2 of Ang II while potassium chloride (KCl) induced contraction was unaltered. Ang II induced contractile response was blocked by valsartan (100 microM, selective AT1 receptor antagonist) but not PD 123,319 (100 microM, selective and potent AT2 receptor antagonist). Exposure of aortic rings from control rats to 25 mM mannitol or sucrose for 2 h did not have any effect on the Ang II induced contraction. Tempol (100 microM, a cell permeable superoxide dismutase mimetic) partially reduced the augmented Ang II response in HG exposed aortic rings, while it did not affect the Ang II responses in normal glucose (NG 5.5 mM) exposed aortic rings isolated from control rats. [3H] Ang II binding at AT1 receptors was unaltered in vascular smooth muscle membranes prepared from thoracic aorta exposed to HG for 2 h compared to NG exposed aortic rings. From our results, we conclude that high glucose concentration augments Ang II mediated contraction via AT1 receptors and reactive oxygen species partly contribute to this augmented contraction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501693     DOI: 10.1016/j.phrs.2004.06.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  8 in total

1.  Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome.

Authors:  Ivan Dimitrijevic; Ulf Ekelund; Marie-Louise Edvinsson; Lars Edvinsson
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

2.  Increased AT1 receptor expression mediates vasoconstriction leading to hypertension in Snx1-/- mice.

Authors:  Chao Liu; Xingyue Li; Jinjuan Fu; Ken Chen; Qiao Liao; Jialiang Wang; Caiyu Chen; Hao Luo; Pedro A Jose; Yongjian Yang; Jian Yang; Chunyu Zeng
Journal:  Hypertens Res       Date:  2021-05-10       Impact factor: 3.872

3.  The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells.

Authors:  Cristina Balia; Valentina Scalise; Silvana Cianchetti; Francesca Faita; Tommaso Neri; Vittoria Carnicelli; Riccardo Zucchi; Alessandro Celi; Roberto Pedrinelli
Journal:  J Inflamm (Lond)       Date:  2016-05-04       Impact factor: 4.981

4.  Exogenous Angiotensin I Metabolism in Aorta Isolated from Streptozotocin Treated Diabetic Rats.

Authors:  P P Wołkow; B Bujak-Giżycka; J Jawień; R Olszanecki; J Madej; J Rutowski; R Korbut
Journal:  J Diabetes Res       Date:  2016-10-10       Impact factor: 4.011

Review 5.  Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets.

Authors:  Misganaw Asmamaw Mengstie; Endeshaw Chekol Abebe; Awgichew Behaile Teklemariam; Anemut Tilahun Mulu; Assefa Agegnehu Teshome; Edgeit Abebe Zewde; Zelalem Tilahun Muche; Muluken Teshome Azezew
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

6.  Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.

Authors:  Ivan Dimitrijevic; Marie-Louise Edvinsson; Qingwen Chen; Malin Malmsjö; Per-Ola Kimblad; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2009-08-25       Impact factor: 2.298

7.  Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

Authors:  Robert Jackson; Sean Brennan; Peter Fielding; Mark W Sims; R A John Challiss; David Adlam; Iain B Squire; Richard D Rainbow
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

Review 8.  Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease.

Authors:  Stella Bernardi; Andrea Michelli; Giulia Zuolo; Riccardo Candido; Bruno Fabris
Journal:  J Diabetes Res       Date:  2016-08-29       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.